Encompass Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Hold
2,937
0.32% 43
2026
Q1
$1.03M Sell
2,937
-60
-2% -$21.4K 0.36% 43
2025
Q4
$981K Sell
2,997
-3,010
-50% -$955K 0.33% 43
2025
Q3
$1.7M Hold
6,007
0.58% 33
2025
Q2
$1.68M Buy
6,007
+2
+0% +$567 0.61% 31
2025
Q1
$1.87M Sell
6,005
-15
-0.2% -$4.43K 0.76% 26
2024
Q4
$1.57M Sell
6,020
-1,596
-21% -$474K 0.63% 29
2024
Q3
$2.45M Sell
7,616
-4
-0.1% -$1.31K 0.61% 31
2024
Q2
$2.38M Buy
7,620
+2,502
+49% +$735K 0.63% 29
2024
Q1
$1.46M Sell
5,118
-918
-15% -$269K 0.39% 55
2023
Q4
$1.74M Sell
6,036
-9
-0.1% -$2.45K 0.52% 37
2023
Q3
$1.62M Sell
6,045
-418
-6% -$104K 0.54% 39
2023
Q2
$1.44M Sell
6,463
-10
-0.2% -$2.32K 0.47% 42
2023
Q1
$1.56M Buy
6,473
+165
+3% +$40.5K 0.53% 38
2022
Q4
$1.66M Sell
6,308
-50
-0.8% -$13.4K 0.6% 34
2022
Q3
$1.43M Sell
6,358
-156
-2% -$37.8K 0.55% 39
2022
Q2
$1.58M Sell
6,514
-44
-0.7% -$10.8K 0.56% 37
2022
Q1
$1.59M Hold
6,558
0.4% 44
2021
Q4
$1.48M Buy
6,558
+3
+0% +$633 0.36% 52
2021
Q3
$1.39M Sell
6,555
-3,993
-38% -$919K 0.36% 51
2021
Q2
$2.57M Hold
10,548
0.63% 36
2021
Q1
$2.61M Buy
10,548
+44
+0.4% +$10.5K 0.67% 34
2020
Q4
$2.42M Buy
+10,504
New +$2.42M 1.39% 15

Other funds holding AMGN

Encompass Wealth Advisors's AMGN Position: Q2 2026 in Review

Encompass Wealth Advisors held its Amgen (AMGN) position steady in Q2 2026 at 2,937 shares worth $1.06M. The position accounts for 0.32% of the portfolio, ranked #43.

Encompass Wealth Advisors first reported a position in AMGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.61M in Q1 2021. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Encompass Wealth Advisors held 2,937 shares of Amgen worth $1.06M as of Q2 2026.
  • Encompass Wealth Advisors left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.32% of Encompass Wealth Advisors's portfolio in Q2 2026, its #43 holding.
  • Encompass Wealth Advisors first reported a position in Amgen in Q4 2020 and has held it in 23 quarters since.
  • Encompass Wealth Advisors's Amgen position peaked at $2.61M in Q1 2021.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Encompass Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.